Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation
Recruiting
Observational Study
Atrial Fibrillation and Flutter
Heart Failure
Artificial Intelligence (AI)
Echocardiography
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 3,000 (estimated)
- Sponsor
- University in Zielona Góra · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational registry is to collect a curated dataset of multimodal imaging data that will serve for development of artificial-intelligence based solutions for prediction of risk and outcomes in patients with atrial fribrillation.
Type of study: observational study
Study Participants: Patients with atrial fibrillation or atrial flutter who undergo clinically indicated transesop…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
\- All patients with AF or AFl in whom TEE will be performed (to assess their eligibility for cardioversion or ablation), hospitalized in a participating center during study period (all consecutive patients).
Exclusion Criteria:
Age\<18, lack of informed, written consent to…
Contacts